Study HighlightsP.R.O.O.F study complete, marking an important catalyst. Conexeu has completed its P.R.O.O.F (Performance and Regeneration ...
Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the 26-week results (Part B) from its second ongoing Phase 3 ...
Brown University researchers have developed a new artificial intelligence method for predicting the rate at which materials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results